BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30054801)

  • 1. Global HBV burden: guesstimates and facts.
    Ginzberg D; Wong RJ; Gish R
    Hepatol Int; 2018 Jul; 12(4):315-329. PubMed ID: 30054801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends of chronic HBV infection over prior decades - A global analysis.
    Ott JJ; Horn J; Krause G; Mikolajczyk RT
    J Hepatol; 2017 Jan; 66(1):48-54. PubMed ID: 27592304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
    Ott JJ; Stevens GA; Groeger J; Wiersma ST
    Vaccine; 2012 Mar; 30(12):2212-9. PubMed ID: 22273662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups.
    Schmit N; Nayagam S; Thursz MR; Hallett TB
    Int J Epidemiol; 2021 May; 50(2):560-569. PubMed ID: 33367672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B: an important public health issue.
    Maddrey WC
    J Med Virol; 2000 Jul; 61(3):362-6. PubMed ID: 10861647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
    Schweitzer A; Horn J; Mikolajczyk RT; Krause G; Ott JJ
    Lancet; 2015 Oct; 386(10003):1546-55. PubMed ID: 26231459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015).
    Ofori-Asenso R; Agyeman AA
    BMC Infect Dis; 2016 Mar; 16():130. PubMed ID: 26987556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global epidemiology of hepatitis B virus.
    Custer B; Sullivan SD; Hazlet TK; Iloeje U; Veenstra DL; Kowdley KV
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S158-68. PubMed ID: 15602165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Chronic Hepatitis B Virus Infection in the United States.
    Lim JK; Nguyen MH; Kim WR; Gish R; Perumalswami P; Jacobson IM
    Am J Gastroenterol; 2020 Sep; 115(9):1429-1438. PubMed ID: 32483003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy.
    Andriamandimby SF; Olive MM; Shimakawa Y; Rakotomanana F; Razanajatovo IM; Andrianinarivomanana TM; Ravalohery JP; Andriamamonjy S; Rogier C; Héraud JM
    BMC Public Health; 2017 Aug; 17(1):636. PubMed ID: 28778194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus burden in developing countries.
    Zampino R; Boemio A; Sagnelli C; Alessio L; Adinolfi LE; Sagnelli E; Coppola N
    World J Gastroenterol; 2015 Nov; 21(42):11941-53. PubMed ID: 26576083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demography and presentation of chronic hepatitis B virus infection.
    Heathcote EJ
    Am J Med; 2008 Dec; 121(12 Suppl):S3-11. PubMed ID: 19185072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of chronic hepatitis B in Albania: a country that is still highly endemic for HBV infection.
    Kondili LA; Brunetto MR; Maina AM; Argentini C; Chionne P; La Sorsa V; Resuli B; Mele A; Rapicetta M
    J Med Virol; 2005 Jan; 75(1):20-6. PubMed ID: 15543588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status.
    Hennessey K; Mendoza-Aldana J; Bayutas B; Lorenzo-Mariano KM; Diorditsa S
    Vaccine; 2013 Dec; 31 Suppl 9():J85-92. PubMed ID: 24331026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012-2014.
    Harris AM; Schoenbachler BT; Ramirez G; Vellozzi C; Beckett GA
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):20-8. PubMed ID: 27168657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
    Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
    J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Karatapanis S; Skorda L; Marinopoulos S; Papastergiou V; Drogosi M; Lisgos P; Antsaklis A
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):878-83. PubMed ID: 22588307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.